Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage
biopharmaceutical company developing a portfolio of potent new
antibiotics designed to be effective against dangerous, drug-resistant
... read more
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH) today reported financial
results for the first quarter ended March 31, 2013.
"Following our successful initial public ... read more
Tetraphase
Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that it has
presented results from studies that demonstrate efficacy of two
next-generation antibiotic candidates against ... read more
Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH), a clinical-stage
biopharmaceutical company developing a portfolio of potent new
antibiotics designed to be effective against dangerous, drug-resistant
... read more
Tetraphase
Pharmaceuticals, Inc. (NASDAQ:TTPH) today announced that the
underwriters for its initial public offering have exercised their
over-allotment option and purchased an ... read more
Tetraphase
Pharmaceuticals, Inc., today announced that it has filed a
registration statement on Form S-1 with the U.S. Securities and Exchange
Commission ... read more